Identification of Integrin ab Expression in Lung Cancer Patients

Clinical trial NCT06167941 · COMPLETED

Trial details

NCT number: NCT06167941
Sponsor: Korea University Guro Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Expression of Integrin ανβ3 in Lung Cancer

Start date: 2019-12-19
Primary completion: 2021-09-10
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.